Trial Profile
Investigation of the visceral fat and adipocytokine by SGLT2 inhibitors in type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Mar 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Mar 2018 Status changed from active, no longer recruiting to completed.
- 19 Jun 2016 New trial record